Terremoto Biosciences

Terremoto Biosciences

Biotechnology Research

South San Francisco, California 4,406 followers

About us

Terremoto Biosciences is a covalent drug discovery and development engine creating highly targeted, small molecule medicines with unmatched selectivity, potency and efficacy. The company leverages the power of lysine-based covalency across the disease spectrum to develop both best-in-class therapies against known drug targets and first-in-class medicines against the previously undruggable. Many of Terremoto’s founders helped establish this emergent area of science, with the intent to broaden the number of tractable targets and deliver medicines with superior therapeutic benefit. Terremoto is supported by leading investors OrbiMed and Third Rock Ventures. More information is available at www.terremotobio.com.

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
South San Francisco, California
Type
Privately Held

Locations

Employees at Terremoto Biosciences

Updates

Similar pages

Browse jobs

Funding

Terremoto Biosciences 2 total rounds

Last Round

Series B

US$ 175.0M

See more info on crunchbase